Scientific Poster , Human ADME , Formulation Development , Clinical Pharmacology , First-in-Human

AAPS 2016 Poster: Formulation selection and development for ME-401 during a first-in-human study in healthy volunteers

7 November 2017
  • Home
  • Resources
  • AAPS 2016 Poster: Formulation selection and development for ME-401 during a first-in-human study in healthy volunteers
Overview

Formulation selection and development for ME-401, an oral, potent, and selective inhibitor of phosphatidylinositol 3-kinase P110δ during a first-in-human study in healthy volunteers.

Read our scientific poster today titled, 'Formulation Selection and Development for ME-401 Suring a First-in-human Study in Healthy Volunteers.'

Download
Download Now
Date
7 November 2017